List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 11 studies with search of: "Immunoconjugates"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Active, not recruiting Monoclonal Antibody Therapy in Treating Patients With Recurrent Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
Conditions: Leukemia;   Lymphoma
Intervention: Biological: B43-genistein immunoconjugate
2 Active, not recruiting Monoclonal Antibody Therapy and Docetaxel in Treating Women With Metastatic or Recurrent Breast Cancer
Condition: Breast Cancer
Interventions: Drug: cBR96-doxorubicin immunoconjugate;   Drug: docetaxel
3 Active, not recruiting SGN-15 And Docetaxel in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: cBR96-doxorubicin immunoconjugate;   Drug: docetaxel
4 Completed Study of SGN-15, Antibody-Drug Conjugate, to Treat Hormone Refractory Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: SGN-15 (cBR96-doxorubicin immunoconjugate);   Drug: Taxotere (docetaxel)
5 Terminated Safety/Efficacy Study of SGN-15 (Antibody-Drug Conjugate) Combined With Gemcitabine in Patients With Ovarian Cancer
Condition: Ovarian Neoplasms
Interventions: Drug: SGN-15 (cBR96-Doxorubicin Immunoconjugate);   Drug: Gemzar (Gemcitabine)
6 Completed Safety/Efficacy Study of Immunoconjugate With Docetaxel in Non-Small Cell Lung Carcinoma
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: SGN-15;   Drug: Docetaxel
7 Recruiting Safety Study of a Radiolabeled Antibody (7E11) in Patients With Progressive Hormone Refractory Prostate Cancer
Condition: Metastatic Prostate Cancer
Intervention: Drug: 177Lu-CYT-500
8 Active, not recruiting Glioblastoma Multiforme (GBM) Locoregional Agent Survival Study - Anti-Tenascin Radiolabeled Antibody Therapy
Condition: Glioblastoma Multiforme
Interventions: Drug: Neuradiab + Radiotherapy + Temozolomide;   Drug: Radiation Therapy + Temozolomide
9 Completed FDG-PET to Investigate SGN-15 and Docetaxel in Patients With Advanced Non-Small Cell Lung Carcinoma
Condition: Non-Small Cell Lung Carcinoma
Intervention: Drug: SGN-15, Docetaxel
10 Recruiting Treatment of Patients With Advanced Renal Cancer With a Radio-Labeled Antibody, Yttrium-90 Conjugated Chimeric G250
Conditions: Renal Cell Carcinoma;   Kidney Neoplasm;   Renal Cancer;   Kidney Cancer
Intervention: Drug: Yttrium-90 conjugated chimeric G250 (90Y-cG250)
11 Recruiting Radioimmunoimaging of AL Amyloidosis
Condition: Primary Amyloidosis
Intervention: Biological: 124I-labeled monoclonal antibody Mu 11-1F4

Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services